XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 38.04

Change

0.00 (0.00)%

Market Cap

CAD 0.59B

Volume

3.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-06 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-0.08 (-0.06%)

CAD 21.96B
ZSP:CA BMO S&P 500

-0.06 (-0.08%)

CAD 18.70B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.18 (-0.34%)

CAD 11.35B
VUN:CA Vanguard US Total Market

-0.13 (-0.14%)

CAD 11.29B
XUS:CA iShares Core S&P 500 Index ETF

-0.30 (-0.67%)

CAD 8.82B
HXS:CA Global X S&P 500 Corporate Cla..

+0.33 (+0.44%)

CAD 4.70B
VSP:CA Vanguard S&P 500 CAD hedged

-0.29 (-0.35%)

CAD 4.14B
QUU:CA Mackenzie US Large Cap Equity ..

-2.49 (-1.19%)

CAD 3.65B
XUU:CA iShares Core S&P US Total Mark..

-0.05 (-0.09%)

CAD 3.46B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.01 (+0.02%)

CAD 3.34B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.30% 12% F 18% F
Dividend Return 0.20% 19% F 7% C-
Total Return -15.10% 12% F 19% F
Trailing 12 Months  
Capital Gain 1.39% 59% D- 47% F
Dividend Return 1.02% 26% F 17% F
Total Return 2.41% 53% F 40% F
Trailing 5 Years  
Capital Gain 88.22% 72% C 75% C
Dividend Return 7.86% 23% F 11% F
Total Return 96.08% 70% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 14.80% 76% C+ 80% B-
Dividend Return 15.71% 75% C 77% C+
Total Return 0.91% 32% F 37% F
Risk Return Profile  
Volatility (Standard Deviation) 15.20% 37% F 54% F
Risk Adjusted Return 103.31% 61% D- 94% A
Market Capitalization 0.59B 53% F 62% D

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.